Patricia Hurter is the founder of Lyndra Therapeutics. Lyndra Therapeutics has raised $146M in total funding. Latest round: Series B. Based in Cambridge, MA.
Patricia Hurter is the Chief Executive Officer of Lyndra Therapeutics, a clinical-stage biopharmaceutical company developing long-acting oral therapies. She joined Lyndra as CEO on September 3, 2019, to lead its pivotal trials for schizophrenia and bipolar disorder treatments.
Full founder directory · Investor directory · Company funding database · Fundraising library